20-03-2015

GGGNNNIIIPPPSSSTTT BBBUUULLLLLLEEETTTIIINNN 222000111555 20th March, 2015 Volume No.: 43 Issue No.: 03

Vision

TO REACH THE PINNACLE OF GLORY AS A CENTRE OF EXCELLENCE IN THE FIELD OF PHARMACEUTICAL AND BIOLOGICAL SCIENCES BY KNOWLEDGE

BASED LEARNING AND PRACTICE

Contents • Message from PRINCIPAL• Editorial board• Historical article• News Update• Knowledge based Article• Disease Related Breaking

News• Upcoming Events• Drugs Update• Campus News• Student’s Section• Editor’s Note• Archive

GNIPST Photo Gallery For your comments/contribution OR For Back-Issues, mailto:gnipstbulletin@gmail.com

GURU NANAK INSTITUTE OF PHARMACEUTICAL SCIENCE AND TECHNOLOGY

We bs i t e : ht t p: / / gni ps t. a c. i n

20-03-2015

MESSAGE FROM PRINCIPAL

"It can happen. It does happen. But it can't happen if you quit." Lauren Dane.

‘We are what we repeatedly do. Excellence then is not an act, but a habit.’ Aristotle

It gives me immense pleasure to pen a few words for our e-bulletin. At the onset I would like to thank the last year’s editors and congratulate the newly selected editors for the current year.

Our first consideration is always in the best interest of the students. Our goal is to promote academic excellence and continuous improvement.

I believe that excellence in education is aided by creating a learning environment in which all learners are supported in maximizing their potential and talents. Education needs to focus on personalized learning and instruction, while promoting an education system that is impartial, universally accessible, and meeting the needs of all students.

It is of paramount importance that our learners have sufficient motivation and encouragement in order to achieve their aims. We are all very proud of you, our students, and your accomplishments and look forward to watching as you put your mark on the profession in the years ahead.

The call of the time is to progress, not merely to move ahead. Our progressive Management is looking forward and wants our Institute to flourish as a Post Graduate Institute of Excellence. Steps are taken in this direction and fruits of these efforts will be received by our students in the near future. Our Teachers are committed and dedicated for the development of the institution by imparting their knowledge and play the role of facilitator as well as role model to our students.

The Pharmacy profession is thriving with a multitude of possibilities, opportunities and positive challenges. At Guru Nanak Institute of Pharmaceutical Science and Technology, our focus is on holistic needs of our students.

I am confident that the students of GNIPST will recognize all the possibilities, take full advantage of the opportunities and meet the challenges with purpose and determination.

Excellence in Education is not a final destination, it is a continuous walk. I welcome you to join us on this path.

My best wishes to all.

Dr. A. Sengupta

Click here to go at the top

1

20-03-2015

EDITORIAL BOARD

CHIEF EDITOR DR. ABHIJIT SENGUPTA EDITOR MS. JEENATARA BEGUM ASSOCIATE EDITOR MR. DIPANJAN MANDAL

HISTORICAL ARTICLE The Father of American Pharmacy: Rarely has a titular distinction been so deserved. William Procter, Jr., graduated from The Philadelphia College of Pharmacy in 1837; operated a retail pharmacy; served the College as Professor of Pharmacy for 20 years; was a leader in founding The American Pharmaceutical Association; served that organization as its first secretary; later, as its president; served 30 years on the U.S.P. Revision Committee; was for 22 years Editor of the American Journal of Pharmacy. In 1869, though retired, Procter continued to edit the Journal in a small publication office located beside the College's Tenth Street building. From retirement he returned to P.C.P.'s chair of Pharmacy in 1872; literally died "in the harness," in 1874.

NEWS UPDATE Measuring treatment response proves to be a

powerful tool for guiding leukemia treatment: (20th March, 2015) Measuring the concentration of leukemia cells in patient bone marrow during the first 46 days of chemotherapy should help boost survival of young leukemia patients by better matching patients with the right intensity of chemotherapy.

Click here to go at the top

2

20-03-2015

Scientists must reduce antibiotic use in experiments: (20th March, 2015) Scientists should reduce antibiotic use in lab experiments. According to a new article, molecular biology and genetic research such as the Human Genome Project use antibiotics in experiments. But it all adds to the global problem of antibiotic resistance according to the author.

Review of global guidelines for sepsis needed: (20th March, 2015) Experts are calling for a global review of guidelines used to diagnose sepsis, after a study found one in eight patients with infections severe enough to need admission to an Intensive Care Unit in Australia and New Zealand, did not meet current criteria.

First blood test for osteoarthritis could soon be available: (20th March, 2015) The first blood test for osteoarthritis could soon be developed, thanks to new research. The research findings could potentially lead to patients being tested for osteoarthritis and diagnosed several years before the onset of physical symptoms.

Autistic and non-autistic brain differences isolated for first time: (20th March, 2015) The functional differences between autistic and non-autistic brains have been isolated for the first time, following the development of a new methodology for analysing MRI scans.

Stinging nettle chemical improves cancer drug: (20th March, 2015) A cancer drug could be made 50 times more effective by a chemical found in stinging nettles and ants, new research finds. Derived from formic acid which is commonly found in a number of natural organisms including nettles and ants, Sodium Formate (E-237) is more commonly used as a food preservative.

Click here to go at the top

3

20-03-2015

America's aging population will require more neurosurgeons to handle increased brain bleeds: (20th March, 2015) By 2030, chronic subdural hemorrhage (SDH) will be the most common adult brain condition requiring neurosurgical intervention in the U.S., according to a new study. And hospitals and neurosurgeons may be under-manned to handle the projected onslaught of patients.

Microscope technique reveals for first time when and where proteins are made: (19th March, 2015) Scientists have developed a fluorescence microscopy technique that for the first time shows where and when proteins are produced. This allows researchers to directly observe individual mRNAs as they are translated into proteins in living cells. It should help reveal how irregularities in protein synthesis contribute to human disease processes, including Alzheimer's disease and other memory-related disorders.

New lead against HIV could finally hobble the virus's edge: (19th March, 2015) Since HIV emerged in the '80s, drug 'cocktails' transformed the deadly disease into a manageable one. But the virus is adept at developing resistance to drugs, and treatment regimens require tweaking that can be costly. Now scientists are announcing new progress toward affordable drugs that could potentially thwart the virus's ability to resist them. For detail mail to editor

Click here to go at the top

4

20-03-2015

KNOWLEDGE BASED ARTICLE H1N1 Influenza (Swine Flu) Medication

Laboratory testing has found the H1N1 influenza A (swine flu) virus susceptible to the prescription antiviral drugs oseltamivir and zanamivir. Other antiviral agents (eg, amantadine, rimantadine) are not recommended because of recent resistance to other influenza strains documented over the past several years. The usual vaccine for influenza administered at the beginning of the flu season is not effective for this viral strain. Also, other antiviral agents (eg, amantadine, rimantadine) are not recommended because of recent resistance to other influenza strains documented over the past several years. Basic supportive care (i.e, hydration, analgesics, cough suppressants) should be prescribed. Empiric antiviral treatment should be considered for confirmed, probable, or suspected cases of H1N1 influenza. Treatment of hospitalized patients and patients at higher risk for influenza complications should be prioritized. WHO guidelines WHO guidelines recommend treating serious cases immediately. The guidelines represent an international panel of experts who reviewed all available studies regarding antiviral agents (with emphasis on oseltamivir and zanamivir). Evidence indicates that oseltamivir, when properly prescribed, significantly decreases risk of pneumonia (a leading cause of death for both pandemic and seasonal influenza) and the need for hospitalization. In the 2009 H1N1 pandemic, oseltamivir-resistant strains were observed in a small number of patients. Most oseltamivir resistance occurred in severely immunocompromised patients with prior exposure to oseltamivir. For patients who initially present with severe illness or whose condition begins to deteriorate, initiate oseltamivir as soon as possible. For patients with severe or deteriorating illness, treatment should be provided even if started later. Where oseltamivir is unavailable or cannot be used for any reason, zanamivir may be given. This recommendation applies to all

Click here to go at the top

5

20-03-2015

patient groups, including pregnant women, and all age groups, including young children and infants. For patients with underlying medical conditions that increase the risk of more severe disease, WHO recommends treatment with either oseltamivir or zanamivir. These patients should also receive treatment as soon as possible after symptom onset, without waiting for the results of laboratory tests. Pregnant women are included among groups at increased risk, and WHO recommends that pregnant women receive antiviral treatment as soon as possible after symptom onset. At the same time, the presence of underlying medical conditions will not reliably predict all or even most cases of severe illness. Worldwide, around 40% of severe cases are now occurring in previously healthy children and adults, usually younger than 50 years. Some of these patients experience a sudden and very rapid deterioration in their clinical condition, usually on day 5 or 6 following the onset of symptoms. Clinical deterioration is characterized by primary viral pneumonia, which destroys the lung tissue and does not respond to antibiotics, and the failure of multiple organs, including the heart, kidneys, and liver. These patients require management in intensive care units using therapies in addition to antivirals. Peramivir, an investigational, intravenous neuraminidase inhibitor in Phase 3 clinical trials, has been used successfully in adults and children under an emergency investigational new drug program in the United States. It was well tolerated and associated with recovery in the majority of patients hospitalized with severe H1N1 infection. Initiate antiviral agents within 48 hours

Prompt initiation of antiviral agents within 48 hours of symptom onset is imperative for providing treatment efficacy against influenza virus. In studies of seasonal influenza, evidence for benefits of treatment is strongest when treatment is started within 48 hours of illness onset. However, some studies of treatment of

Click here to go at the top

6

20-03-2015

seasonal influenza have indicated benefit, including reductions in mortality or duration of hospitalization, even in patients in whom treatment was started more than 48 hours after illness onset. The recommended duration of treatment is 5 days. Prophylaxis with antiviral agents should also be considered in the following individuals (pre-exposure or postexposure):

• Close household contacts of a confirmed or suspected case whoare at high risk for complications (eg, chronic medical conditions, persons >65 y or < 5 y, pregnant women)

• School children at high risk for complications who have been inclose contact with a confirmed or suspected case

• Travelers to Mexico who are at high risk for complications (eg,chronic medical conditions, persons >65 y or < 5 y, pregnant women)

• Health care providers or public health workers who were notusing appropriate personal protective equipment during close contact with a confirmed or suspected case

• In September 2009, the CDC updated recommendationsconcerning the use of antiviral medications for prevention because of reported oseltamivir resistance; antivirals should not be used for postexposure chemoprophylaxis in healthy children or adults to manage outbreaks in the community, school, camp, or other settings.

• Reserve antiviral chemoprophylaxis for persons at higher riskfor influenza-related complications who have had contact with someone likely to have been infected with influenza. Pre-exposure prophylaxis can be considered in the following persons:

• Any health care provider who is at high risk for complications(eg, persons with chronic medical conditions, adults >65 y, pregnant women)

• Individuals not considered to be at high risk but who arenonetheless traveling to Mexico, first responders, or border workers who are working in areas with confirmed cases

Click here to go at the top

7

20-03-2015

• Oseltamivir ring prophylaxis can be considered for outbreaks ofpandemic H1N1 influenza A, especially among closed populations such as military personnel; ring prophylaxis involved the use of oseltamivir 75 mg once daily to members of the same military unit where contact opportunities were substantial. Pediatric considerations Aspirin or aspirin-containing products (eg, bismuth subsalicylate [Pepto Bismol]) should not be included in the treatment of confirmed or suspected viral infection in persons aged 18 years or younger because of the risk of Reye syndrome. For relief of fever, other antipyretic medications (eg, acetaminophen, nonsteroidal anti-inflammatory drugs) are recommended. Pregnant women Oseltamivir and zanamivir are "Pregnancy Category C" medications, indicating that no clinical studies have been conducted to assess the safety of these medications in pregnant women. Because of the unknown effects of influenza antiviral drugs on pregnant women and their fetuses, oseltamivir or zanamivir should be used during pregnancy only if the potential benefit justifies the potential risk to the embryo or fetus; the manufacturers' package inserts should be consulted. However, no adverse effects have been reported among women who received oseltamivir or zanamivir during pregnancy or among infants born to women who have received oseltamivir or zanamivir. Prompt use of antiviral drugs during the 2009 H1N1 influenza pandemic improved survival among severely ill pregnant women. The CDC examined reports of severe flu (resulting in death or ICU admission) in 347 pregnant women during the pandemic, including 272 who were admitted to the ICU and survived and 75 who died. Severely ill postpartum women (n=15), including 9 who died, also were reported. Of the 307 pregnant women for whom information regarding the presence of underlying medical conditions was available, half had underlying conditions such as asthma, diabetes, or hypertension.

Click here to go at the top

8

20-03-2015

Among those who died, 86.1% received antiviral treatment with oseltamivir or zanamivir, compared with 94.8% of survivors. Time to initiate treatment from symptom onset was significantly different for women who died, compared with those who survived (P < .01). Only 4 women (7%) of those who died received an antiviral within 2 days of symptom onset, compared with 41% of survivors. This analysis reaffirms the importance of prevention (ie, vaccination of pregnant women regardless of trimester) and prompt treatment with a neuraminidase inhibitor (ie, within 2 d of symptom onset) if influenza occurs during pregnancy. Pregnancy should not be considered a contraindication to oseltamivir or zanamivir use. Because zanamivir is an inhaled medication and has less systemic absorption, some experts prefer zanamivir over oseltamivir for use in pregnant women, when feasible. Others recommend that, because pregnant women may have a decreased ability to inhale zanamivir, they should be given oseltamivir.

Jeenatara Begum Assistant Professor

GNIPST

DISEASE RELATED BREAKING NEWS Middle East respiratory syndrome coronavirus

(MERS-CoV) – Saudi Arabia: (20th March, 2015) Between 3 and 10 March 2015, the National IHR Focal Point for the Kingdom of Saudi Arabia notified WHO of 15 additional cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection, including 5 deaths. Cases are listed by date of reporting, with the most recent case listed first. Read more

Click here to go at the top

9

20-03-2015

UPCOMING EVENTS On 21st March, 2015 GUJCOST Sponsored seminar is going to held

on Ethics: Essential Component of Clinical Research in Anand Pharmacy College, Anand, Gujrat.

Master class Opthalmic Oncology Conference 2015 is going to held on 28th to 29th March, 2015 in Mumbai, India.

DRUGS UPDATES Actavis Receives FDA Approval for Viibryd

(vilazodone HCl) 20mg Once Daily as a Therapeutic Dose: (16th March, 2015)Actavis plc (NYSE: ACT) announced the U.S. Food and Drug Administration (FDA) has approved a lower therapeutic dose of Viibryd (vilazodone HCl) (20mg) to accompany the 40 mg daily therapeutic dose. This supplemental new drug application (sNDA) approval for Viibryd expands dosing options available to health care providers when using VIIBRYD to treat their adult patients with MDD. The Viibryd 20mg therapeutic dose is now available in pharmacies. Read more

CAMPUS NEWS All the students of Final Year B. Pharm and M. Pharm are hereby

informed that an interview will be conducted from GSK for sales and marketing job. Details given below:

Date : 27.03.2015 Time : 09:45 am Venue : GSK Consumer Healthcare Limited, Unit No. 208,

2nd Floor, Ecospace Campus B (3 B), New Town, Rajarhat, 24 Pgs (N). Kolkata-700156.

Click here to go at the top

10

20-03-2015

On 14th March, 2015 Mr. Milindra Bhattacharya, Senior Manager, QA & QC, Emami Ltd. and Mr. Joydev Bhoumik, Manager, Operation, Ranbaxy Laboratory Limited delivered their valuable lectures in the 3rd day FINISHING SCHOOL TRAINING PROGRAMME of GNIPST.

Congratulations to Anurag Chanda, student of B.Pharm final year who have got the 1st prize in poster presentation event in Prakriti 2015 at Department of Agricultural and Food engineering, IIT, Kharagpur.

THYROCARE provisionally selected 15 students from JIS Group. Amongst these, 3 students of B. Sc (H) Biotechnology and M. Sc Biotechnology have been selected.

Ipsita Mondal (M. Sc Biotechnology) Debriti Paul (M. Sc Biotechnology) Debopriya Chatterjee {B. Sc (H) Biotechnology} The final year students of B.Pharm (31 students) and B.Sc (11

students) attended the pooled campus drive of Abbott India Ltd. on 10th March, 2015 at Jadavpur University. Among them 17 students have gone through to the final round of this pooled campus drive and short listed for final selection.

On 28th February, 2015 Dr. D. Roy, Former Deputy Drug Controller, Mr. Sujoy Chakraborty, divisional Therapy Manager, Cipla and Mr. Vikranjit Biswas, Senior Manager, Learning & Development, Cipla delivered their valuable lectures in the 2nd day FINISHING SCHOOL TRAINING PROGRAMME of GNIPST.

On 24th and 25th February, 2015 Swamiji of Gourio Math was delivered some motivational lectuers in GNIPST.

On 21st February, 2015 the Finishing School Training Programme of GNIPST was inaugurated by Sri Soumen Mukhopadhyay, Deputy Director, Drug Control Office, Goutam Kr. Sen, President, IPGA, Mr. Subroto Saha, Asst. Directorate, Drug Control Office, Mr.

Click here to go at the top

11

20-03-2015

Ranendra Chakraborty, Sales Manager and Associate Director Dr. Reddys Laboratory.

The FINISHING SCHOOL TRAINING PROGRAMME is going to organize by the Entrepreneurship Development Cell and Training & Placement Cell, GNIPST in collaboration with Indian Pharmacy Graduates’ Association (IPGA), Bengal Branch from 21st February to 11th April, 2015 at GNIPST Auditorium.

The students of GNIPST participated in the 4th

Sardar Jodh SinghTrophy organised by NIT on 20th February, 2015.

On 8th February, 2015 Gnipst celebrated the Reunion programme “Reminiscence Reloaded 2015”.

The 2nd Annual Sports of GNIPST was held on 28th and 29th January,2015 in College campus ground.

Congratulations to all the winner of Annual Sports of GNIPST, 2015.

100 meter flat race (Girls): Priya Roy Nirmita Gupta Joyoti Ghosh

100 meter flat race (Boys): Arijit Mitra Thakur Deep Chakraborty Arindam Ganguly Three legged race (Girls):

Nayana Sinha Anjali Mondal Saheli Mukherjee Arjita Biswas Aindrila Bhowmick Archita Basu

200 meter flat race (Girls): Priya Roy Nirmita Gupta Anjali Mondal Long Jump (Boys): Dipankar Kamila Arindam Ganguly Rohan Datta Skipping (Girls): Saheli Mukherjee Indira Saha Jayita Roy Shotput (Girls): Chandrika Saha Priya Roy Sneha Paul Shotput (Boys): Arijit Mitra Thakur Arindam Ganguly Rohan Datta Musical Chair (Staff): Mr. Abir Koley Ms. Priyanka Ray Mr. Debabrata Ghoshdastidar

Click here to go at the top

12

20-03-2015

Discuss Throw(Girls): Priya Roy Arjita Biswas Varsha Shrivastava 50 meter female flat race (staff): Ms. Aparupa Bhattacharya Ms. Priyanka Ray Ms. Anuranjita

Kundu

100 meter male flat race (staff): Mr. Debabrata Ghoshdastidar Mr. Mrinal Datta Mr. Ranjit

Ghosh Walking race female (staff): Ms. Aparupa Bhattacharya Ms. Anuranjita Kundu Ms. Sumana Roy Balance race female (staff): Ms. Aparupa Bhattacharya Dr. Sriparna KunduSen Ms. Priyanka Ray Tug of war (Female staff): Ms. Priyanka Ray Ms. Aparupa Bhattacharya Ms. Prathama SenGupta Dr. Sriparna KunduSen Ms. Sumana Roy Tug of war (Male staff): Mr. Debabrata Ghoshdastidar Mr. Abir Koley Sk. Ziaur Rahman Mr. Ranjit Ghosh Mr. Koushik Dhar Balance race (Girls): Indira Saha Aindrila Bhowmick Pamolita Paul Long Jump (Girls):

Click here to go at the top

13

20-03-2015

Aindrila Bhowmick Nirmita Gupta Krishnakali Basu 200 meter flat race (Boys): Dipankar Kamila Arijit Mitra Thakur Kaustav Sakar Sack race (Girls): Aindrila Bhowmick Nirmita Gupta Sayani Banerjee Sack race (Boys): Rohan Datta Souvik Debnath Sayantan Das Relay race (Boys): Dipankar Kamila Arijit Mitra Thakur Soumyajit Sinha Sneham Sen Relay race (Girls): Joyoti Ghosh Aindrila Bhowmick Anjali Mondal Poulami Sarkar Go for Goal (Boys): Abhijit Kumar Mondal Arkajyoti Hazra Abhinandan Mondal Tug of war (Boys): Dipu Roy Vishal Singh Sk Minhaz Uddin Ahmed Ritobroto Paul Rohan Dutta

Click here to go at the top

14

20-03-2015

Tug of war (Girls): Krishnakali Basu Indira Saha Chandrika Saha Maitryee Banerjee Kajal Nagpal

The male faculties and staffs of GNIPST participated in the 4th

Sardar Jodh Singh Trophy organised by NIT on 15th January, 2015. An industrial tour and biodiversity tour was conducted in Sikkim

for B.Pharm, B.Sc. and M.Sc. students under the supervision of Mr. Dipanjan Mandal, Mr. Samrat Bose and Ms. Aparupa Bhattacharya from 5th January to 12th January, 2015.

GNIPST commemorated the Birth Anniversary of Swami Vivekananda on Monday, 12th January, 2015 & served Oldages and Orphanages.

On 22nd December 2014 the students of B.Pharm 2nd year and B.Sc 2nd year visited the laboratory of Vivekananda Institute of Biotechnology, Sri Ramkrishna Ashram, Nimpith under the supervision of Mr. Samrat Bose, Ms Jeentara Begum, Mr. Soumya Bhattacharya and Ms. Aparupa Bhattacharya.

Some of the teachers of GNIPST attended the 4th International Conference of World Science Congress at Jadavpur University on 16th December to 18th December 2014.

Congratulation to Tamalika Chakraborty, Assistant Professor of GNIPST, who got 3rd prize for the poster presentation in the National Seminar on Opportunity in Medicinal Plant Research, Jadavpur University, Kolkata, India from 29th -30th November, 2014.

On 29th November and 30th November many of the faculty members and students of GNIPST presented their posters in the National Seminar on Opportunity in Medicinal Plant Research,

Click here to go at the top

15

20-03-2015

Jadavpur University, Kolkata, India from 29th -30th November, 2014.

Congratulation to Dr. Swati Chakraborty, Assistant Professor of GNIPST, who got 1st prize for the best oral presentation in the India Biodiversity Meet, 2014 at Indian Statistical Institute, Kolkata, India from 21st -23rd November, 2014.

The teachers and students of GNIPST attended the National workshop on “Redefining the Role of Pharmacist in Health Care System” which was held in Dr. H. L. Roy Auditorium, Jadavpur Universirty Kolkata-700032 on 16th November 2014, organised by Indian Pharmaceutical Association, Bengal Branch, Kolkata

Congratulation to Rupam Saha, student of M.Pharm 2nd year, who got 1st prize for the poster presentation in the National seminar on Control of Viral Menace using Delivery Design organised by Dr. B.C.Roy College of Pharmacy & AHS in association with IPA Bengal Branch.

On 14th and 15th November 2014 the Industrial visit of B.Pharm 2nd year students was conducted in East India Pharmaceutical Works Limited, Kolkata under the supervision of Mr. Jaydip Roy, Mr. Debabrata Ghoshdastidar, Mr. Samrat Bose, Ms Jeentara Begum, Mr. Soumya Bhattacharya and Ms. Moumita Chowdhury.

A Debate on ‘Unity’ was held on 14th November 2014 and the joint winner was Sreejit Roy , Bsc 2nd year and Pratik Nandi ,Bsc first year (Chairperson of debate: Dr Lopamudra Datta and Ms. Priyanka Ray).

On 14th November, 2014 a Quiz competition was held on ‘World Diabetes Day’ and the winner was Pratik Nandi and Sreyosi Dey, Bsc first year. Runner up Anirban Roy and Ankur Mondal B.Pharm third year (Quiz Master: Mr. Soumya Bhattacharya)

Click here to go at the top

16

20-03-2015

A Seminar was held on 14th November 2014 World Diabetes Day on ‘Angiogenesis and Role of Amino Acids’ by Dr Debatosh Datta, Research scientist.

GNIPST commemorated the 126th Birth Anniversary of Maulana Abul Kalam Azad on Tuesday, 11th November 2014.

On 7th November 2014 the students of GNIPST participated in the ‘Run for Unity’ as a mark of tribute to the efforts of the country's first Home Minister Sardar Vallabhbhai Patel.

Congratulation to the winner of Cricket Tournament-B.Pharm 3rd year, 2014 Runner up team-B.Sc and BHM, 2014

Congratulation to the highest run scorer of Cricket Tournament-Tanmoy Das Biswas, B.Pharm 3rd year, 2014

Congratulation to the highest wicket taker of Cricket Tournament-Subhodip Das, B.Pharm 3rd year, 2014

Congratulation to the winner of Carom Tournament (Boys)- Sk. Abdul Salam, B.Pharm 2nd year, 2014 1st Runner up-Subhayan Dutta, M.Sc (Biotechnology Department) 2nd year, 2014 2nd Runner up-Nirupan Gupta, B.Pharm 1st year, 2014

Congratulation to the winner of Carom Tournament (Girls)- Aishwarya Datta, B.Pharm 2nd year, 2014 1st Runner up-Krishnakali Basu, B.Pharm 3rd year, 2014 2nd Runner up-Rituparna Das, B.Pharm 3rd year, 2014

Congratulation to the winner of Chess Tournament (Boys)- Basab Brata Dey, M.Sc (Biotechnology Department) 2nd year, 2014 1st Runner up-Ankit Chowdhury, B.Pharm 1st year, 2014 2nd Runner up-Smaranjeet Banik, B.Pharm 3rd year, 2014

Congratulation to the winner of Chess Tournament (Girls)- Rituparna Das, B.Pharm 3rd year, 2014 1st Runner up-Varsa Srivastav, B.Sc(Bioptechnology Department) 1st year, 2014

Click here to go at the top

17

20-03-2015

2nd Runner up- Krishnakali Basu, B.Pharm 3rd year, 2014

The GNIPST Cricket Tournament, Carom Tournament and Chess Tournament was held on 21st and 22nd October, 2014.

The Cultural Programme on Bijoya Dashami and Kali Puja was held on 20th October, 2014

An exhibition on Photography and Painting was held on 20th October, 2014

Congratulation to the winner of Football Tournament-B.Pharm 3rd year, 2014 Runner up team-B.Pharm final year, 2014

Congratulation to the winner of Table Tennis Tournament-Krishnakali Basu, B.Pharm 3rd year, 2014 1st Runner up-Aindrila Bhowmick, B.Pharm 2nd year, 2014 2nd Runner up-Sayani Banerjee, B.Pharm 2nd year, 2014

The GNIPST Football Tournament (for male students) and Table Tennis tournament (for female students) was held on 25th and 26th September, 2014.

On 5th September, 2014 the students of GNIPST have arranged a wonderful Teacher’s Day Programme. On behalf of all the teachers of GNIPST I would like to thank our beloved students.

The Fresher’s welcome programme was held on 14th August, 2014. Welcome 1st year students.

We congratulate the following M.Pharm. final year students who have made their positions in different pharmaceutical companies. Anirban Banerjee (Emami Ltd.) Mahender Roy (Stadmed private Ltd.)

We congratulate the following B.Pharm. final year students for their success. Samadrita Mukherjee (Abbott India Ltd.) Suman Sarkar (Tata Medical Centre-Apollo Pharmacy)

Click here to go at the top

18

20-03-2015

Shrewashee Mukherjee (Fresenius Kabi-Parenteral Nutrition) Avishek Naskar (Glaxo SmithKline-Marketing) Bappaditya Manik (USV Limited) Sarbani Das (Nutri Synapzz-Marketing) Ankita Roy (Nutri Synapzz-Marketing) Rahul Mitra (B M Pharmaceuticals-Production)

The following B.Pharm. final year students have qualified, GPAT-2014. We congratulate them all. Utsha Sinha Satarupa Bhattacharya Sandipan Sarkar Purbali Chakraborty

Reminiscence, 2014(GNIPST Reunion) was held in College campus on 2nd February,2014.

1st Annual Sports of GNIPST was held on 3rd February,2014 in College campus ground.

An industrial tour and biodiversity tour was conducted in Sikkim for B.Pharm and B.Sc. students under the supervision of Mr. Asis Bala, Ms. Jeentara Begum and Ms. Moumita Chowdhury.

B.Pharm 3rd year won the GNIPST Football Champions trophy, 2013. B.Pharm 3rd year won the final match 1-0 against B.Pharm 2nd year. Deep Chakraborty was the only scorer of the final.

Click here to go at the top

19

20-03-2015

STUDENTS’ SECTION

WHO CAN ANSWER FIRST????

Who is the Arjuna awardee in 2014 incricket?

Answer of Previous Issue’s Questions: A) 14th March

Identify the person

Answer of Previous Issue’s Image: Mohammad Nabi, captain of Afganistan Cricket team

Congratulation to ARIJIT PRAMANIK who have given the correct answer-14th March is celebrated

as International pi day

Send your thoughts/ Quiz/Puzzles/games/write-ups or any other contributions for Students’ Section& answers of this Section at gnipstbulletin@gmail.com

Click here to go at the top

20

20-03-2015

EDITOR’S NOTE

It is a great pleasure for me to publish the 3rd issue of 43th Volume of GNIPST BULLETIN. All the followers of GNIPST BULLETIN are able to avail the bulletin through facebook account ‘GNIPST bulletin’ I am very much thankful to all the GNIPST members and readers who are giving their valuable comments, encouragements and supports. I am also thankful to Dr. Abhijit Sengupta, Director of GNIPST for his valuable advice and encouragement. Special thanks to Dr. Prerona Saha, Mr. Debabrata Ghosh Dastidar and Mr. Soumya Bhattacharya for their kind co-operation and technical supports. Thank you Mr. Soumya Bhattacharya for the questionnaires of the student section. An important part of the improvement of the bulletin is the contribution of the readers. You are invited to send in your write ups, notes, critiques or any kind of contribution for the forthcoming special and regular issue.

ARCHIVE The general body meeting of APTI, Bengal Branch has been

conducted at GNIPST on 15th June, 2012. The program started witha nice presentation by Dr. Pulok Kr. Mukherjee, School of NaturalProducts, JU on the skill to write a good manuscript forpublication in impact journals. It was followed by nearly two hourlong discussion among more than thirty participants on differentaspects of pharmacy education. Five nonmember participantsapplied for membership on that very day.

GNIPST is now approved by AICTE and affiliated to WBUT forconducting the two years’ post graduate course (M.Pharm) inPHARMACOLOGY. The approved number of seat is 18.

The number of seats in B.Pharm. has been increased from 60 to120.

Click here to go at the top

21

20-03-2015

AICTE has sanctioned a release of grant under ResearchPromotion Scheme (RPS) during the financial year 2012-13toGNIPST as per the details below:a. Beneficiary Institution: Guru Nanak Institution of PharmaceuticalScience & Technology.

b. Principal Investigator: Dr. LopamudraDutta.

c. Grant-in-aid sanctioned:Rs. 16,25000/- onlyd. Approved duration: 3 years

e. Title of the project: Screening and identification of potentialmedicinal plant of Purulia & Bankura districts of West Bengal with respect to diseases such as diabetes, rheumatism, Jaundice, hypertension and developing biotechnological tools for enhancing bioactive molecules in these plants.

Activity Clubs of GNIPST: Name of Club Member Faculty SPORTS Mr. Debabrata GhoshDastidar LITERARY AND PAINTING Ms. Jeenatara Begum SCIENCE AND INNOVATIVE MODELLING

Mr. Samrat Bose

ECO Ms. Sumana Roy SOCIAL SERVICES Dr. Asis Bala PHOTOGRAPHY Ms. Sanchari Bhattacharya CULTURAL Ms. Priyanka Ray DEBATE AND EXTEMPORE Mr. Soumya Bhattacharya

Click here to go at the top

22